Blood Flow Measurement Devices Market worth 533.0 Million USD by 2021

According to a new market research report Blood Flow Measurement Devices Market is expected to reach USD 533.0 Million by 2021 from USD 343.6 Million in 2016, growing at a CAGR of 9.2%.

Blood Flow Measurement Devices Market by Product (Ultrasound (Transit Time Flow Meter), Laser Doppler), Application (Invasive (CABG, Microvascular Surgery), Non-invasive (Cardiovascular, Gastroenterology & Tumor Monitoring)) – Global Forecast to 2021

Browse 70 market data tables and 42 figures spread through 126 pages and in-depth TOC on “Blood Flow Measurement Devices Market”

http://www.marketsandmarkets.com/Market-Reports/blood-flow-measurement-devices-market-243081818.html

Early buyers will receive 10% customization on this report.

This report studies the global Blood Flow Measurement Devices Market for the forecast period of 2016 to 2021. The global Blood Flow Measurement Devices Market is segmented on the basis of product, application, and region.

Based on product, the Blood Flow Measurement Devices Market is categorized into ultrasound and laser Doppler. In 2016, the ultrasound segment commanded the largest share of the global blood flow measurement device market. This growth can be attributed to the growing applications of ultrasound products, such as vascular diseases and dermatology, and their usability in invasive as well as non-invasive applications. The ultrasound market is further categorized into ultrasound Doppler and transit-time flow meters (TTFM). In 2016, the ultrasound Doppler segment commanded the largest share of the global ultrasound market. The large share and high growth rate of these devices can be attributed to their growing applications, ease of use, and increased preference for non-invasive devices.

Download PDF Brochure @ http://www.marketsandmarkets.com/pdfdownload.asp?id=243081818

Based on application, the Blood Flow Measurement Devices Market is segmented into non-invasive applications and invasive applications. Non-invasive applications are further categorized into cardiovascular disease, diabetes, tumor monitoring, gastroenterology, and others applications (dermatology and intracranial pressure monitoring). The cardiovascular disease segment commanded the largest share of the global blood flow measurement device market, by non-invasive applications, in 2016. The large share and high growth rate of this segment can be attributed to the increasing prevalence of cardiovascular disease, rising geriatric population, and increasing focus of key market players on this market. Similarly, invasive applications are further segmented into coronary arterial bypass graft (CABG), microvascular surgery, and others (organ transplants and reconstructive surgery). The CABG segment commanded the largest share of the global Blood Flow Measurement Devices Market in 2016. The growth in this segment can be attributed to a large number of CABG surgeries performed worldwide.

Get Report Sample @ http://www.marketsandmarkets.com/requestsample.asp?id=243081818

The key players in the Blood Flow Measurement Devices Market include Cook Medical, Inc. (U.S.), Medistim ASA (Norway), Transonic Systems, Inc. (U.S.), ADInstruments (Australia), Moor Instruments Ltd. (U.K.), Deltex Medical Group plc (U.K.), BIOPAC Systems, Inc. (U.S.), Atys Medical (France), Compumedics Ltd. (Australia), Perimed AB (Sweden), and SONOTEC Ultraschallsensorik Halle GmbH (Germany).

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:

Mr. Rohan
MarketsandMarkets
701 Pike Street
Suite 2175, Seattle,
WA 98101, United States
1-888-600-6441
Email: sales@marketsandmarkets.com

This release was published on openPR.